Kanoria Chemicals & Industries Ltd reports Q2 FY27 consolidated revenue of ₹357.98 crore and continuing-operations profit of ₹22.72 crore
- Revenue rose 70.6% year on year and fell 22.2% sequentially; operating margin was 12.9%, versus 8.8% in Q2 FY26.
- Board proposed reappointing Rajya Vardhan Kanoria as MD for three years from 10 January 2027, subject to shareholder approval.
- Auditors issued unmodified limited-review conclusions.
